Featured Research

from universities, journals, and other organizations

Oral Contraceptives Associated With Reduced Risk Of Multiple Sclerosis

Date:
September 29, 2005
Source:
JAMA and Archives Journals
Summary:
Over a three-year period, the risk of developing multiple sclerosis (MS) was reduced in women taking oral contraceptives, according to a study in the September issue of Archives of Neurology, one of the JAMA/Archives journals.

CHICAGO – Over a three-year period, the risk of developingmultiple sclerosis (MS) was reduced in women taking oralcontraceptives, according to a study in the September issue of Archivesof Neurology, one of the JAMA/Archives journals.

Related Articles


In previousstudies, estrogen delayed the onset and eased the course of a MS-likedisease in animals, suggesting that oral contraceptives, which containestrogen, and pregnancy and the postpartum period afterward, bothstates associated with profound hormonal changes, may alter theclinical course or affect the risk of developing the disease, accordingto background information in the article.

Αlvaro Alonso, M.D.,Ph.D., of the Harvard School of Public Health, Boston, and colleaguescompared 106 women who had a new diagnosis of MS between January 1,1993 and December 31, 2000 with 1,001 matched women without MS ascontrols. Individuals included in the analysis were drawn from aresearch database that includes medical and pharmacy records for threemillion Britons.

"The incidence of MS in OC [oral contraceptives]users was 40 percent lower than in nonusers," the authors report."Women had a higher risk of developing first symptoms of MS in the sixmonths following a pregnancy and a non-significant lower risk duringpregnancy, compared with those with no pregnancy. … This is consistentwith studies on the effect of pregnancy in patients with MS and theimmunological changes associated with pregnancy."

"Recent OC useand, possibly, current pregnancy are associated with a lower risk ofdeveloping MS," the authors conclude. "On the contrary, the postpartumperiod confers a higher risk of MS onset. Our findings suggest thathigh levels of exogenous [from outside the body] estrogens from OC useand of endogenous [from the body] estrogens during pregnancy may delaythe first clinical attack of MS."

###

(Arch Neurol. 2005; 62:1362-1365. Available pre-embargo to the media at www.jamamedia.org.)

Editor'sNote: This study was supported by a grant from the National MultipleSclerosis Society, New York, N.Y. Dr. Alonso was supported by aFulbright Program fellowship, New York.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Cite This Page:

JAMA and Archives Journals. "Oral Contraceptives Associated With Reduced Risk Of Multiple Sclerosis." ScienceDaily. ScienceDaily, 29 September 2005. <www.sciencedaily.com/releases/2005/09/050929202016.htm>.
JAMA and Archives Journals. (2005, September 29). Oral Contraceptives Associated With Reduced Risk Of Multiple Sclerosis. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2005/09/050929202016.htm
JAMA and Archives Journals. "Oral Contraceptives Associated With Reduced Risk Of Multiple Sclerosis." ScienceDaily. www.sciencedaily.com/releases/2005/09/050929202016.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins